Advil Liqui Gels, Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules, Distributed by: Pfizer, Madison, NJ 07940, UPC 3 0573 0169 49 3
Published February 1, 2023 · Recall initiated: December 6, 2022
Summary
FDA records drug Class I recall D-0182-2023, published February 1, 2023 and initiated December 6, 2022. Recalling firm: Glaxosmithkline Consumer Healthcare Holdings DBA Haleon; Status: Terminated; Reported quantity: 88,380 capsules; Lot: Lot: R94065, Exp 02/29/2024. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Glaxosmithkline Consumer Healthcare Holdings DBA Haleon
- Distributor
- Nationwide in the USA.
- Lot
- Lot: R94065, Exp 02/29/2024
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAdvil Liqui Gels (minis), Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200February 1, 2023
- FDAAdvil (ibuprofen) Tablets, 200 mg, packaged as a) 360-count bottles (UPC 3 0573 0154 60 4), and b) 200-countFebruary 1, 2023
- FDAEpinephrine (L-Adrenaline), USP, CAS 51-43-4, Packaged in amber glass bottles in a vacuum sealed pouch asFebruary 1, 2023
- FDAVancomycin Hydrochloride for Injection, USP, 1.5 g/vial, Sterile powder, Single-dose Fliptop Vial, 10 vialsFebruary 1, 2023
- FDAEpinephrine (L-Adrenaline), USP, CAS 51-43-4, 1 KG amber glass bottle in a vacuum sealed pouch, Rx only,February 1, 2023
- FDADutasteride 0.1% (1.5ML VIAL) Injectable, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.February 1, 2023
Questions about this recall
Was Advil Liqui Gels, Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules, Distributed by: Pfizer, Madison, NJ 07940, UPC 3 0573 0169 49 3 recalled?
Yes. FDA published recall D-0182-2023 on February 1, 2023. Reported hazard: Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
What should I do if I have this product?
Voluntary: Firm initiated · Letter